Therapeutic Asset Ratings
10,834 results matching 1 filter
103,893 assets · 8,277 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
19-28z/il-18 car t cells
Adult Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
1a46
Cancer
BioRay Pharmaceutical Co., Ltd.
P1
CC
(43)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Inguinal Hernias
Makassed General Hospital
P1
CC
(43)
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-
Kita-kyushu Lung Cancer Antigen 1, Human
National Cancer Institute (NCI)
P1
CC
(43)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Colorectal Carcinoma
Nurix Therapeutics, Inc.
P1
CC
(43)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Gastroesophageal Junction Adenocarcinoma
Nurix Therapeutics, Inc.
P1
CC
(43)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Malignant Pleural Mesothelioma
Nurix Therapeutics, Inc.
P1
CC
(43)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Melanoma
Nurix Therapeutics, Inc.
P1
CC
(43)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Ovarian Carcinoma
Nurix Therapeutics, Inc.
P1
CC
(43)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Richter Transformation
Nurix Therapeutics, Inc.
P1
CC
(43)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Urothelial Carcinoma
Nurix Therapeutics, Inc.
P1
CC
(43)
21.15.gpc3-car t cells
Atypical Teratoid Rhabdoid Tumor
Baylor College of Medicine
P1
CC
(43)
21.15.gpc3-car t cells
Undifferentiated Embryonal Sarcoma Of The Liver
Baylor College of Medicine
P1
CC
(43)
21.15.gpc3-car t cells
Hepatoblastoma
Baylor College of Medicine
P1
CC
(43)
21.15.gpc3-car t cells
Liposarcoma
Baylor College of Medicine
P1
CC
(43)
21.15.gpc3-car t cells
Rhabdoid Tumor
Baylor College of Medicine
P1
CC
(43)
21.15.gpc3-car t cells
Wilms Tumor
Baylor College of Medicine
P1
CC
(43)
21.15.gpc3-car t cells
Yolk Sac Tumor
Baylor College of Medicine
P1
CC
(43)
²¹²pb-dotam-grpr1
Castration-Resistant Prostate Carcinoma
Orano Med Theranostics, SAS
P1
CC
(43)
[212pb]vmt-alpha-net
Digestive System Neuroendocrine Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Esthesioneuroblastoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Head And Neck Cancer
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Kidney Cancer
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
[212pb]vmt-alpha-net
Olfactory Neuroblastoma
National Cancer Institute (NCI)
P1
CC
(43)
Showing 826 to 850 of 10,834 assets
Previous
Page 34 of 434
Next
